A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

Robert G. Maki(Memorial Sloan Kettering Cancer Center), Gerd Ritter(Ludwig Cancer Research)
Sarcoma
January 1, 2013
10.1155/2013/168145
Cited by 180

Related Papers

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
|Journal of Clinical Oncology|2009|573
Malignant Peripheral Nerve Sheath Tumors
|The Oncologist|2014|361
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas
|Cancer|2019|27